Table 2.
Imaging abnormality | No. of patients | Percentage (%) |
---|---|---|
Dilated CBD |
16 |
88.8% |
CBD stone or shadow |
9 |
50% |
Hepatomegaly |
6 |
33.3% |
Liver abscess |
3 |
16.6% |
Gall stone |
2 |
11.1% |
Hepatic cystic lesions | 1 | 5.5% |
Imaging abnormality | No. of patients | Percentage (%) |
---|---|---|
Dilated CBD |
16 |
88.8% |
CBD stone or shadow |
9 |
50% |
Hepatomegaly |
6 |
33.3% |
Liver abscess |
3 |
16.6% |
Gall stone |
2 |
11.1% |
Hepatic cystic lesions | 1 | 5.5% |